These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9129055)
101. How do PIG-A mutant paroxysmal nocturnal hemoglobinuria stem cells achieve clonal dominance? Brodsky RA Expert Rev Hematol; 2009 Aug; 2(4):353-6. PubMed ID: 21082939 [No Abstract] [Full Text] [Related]
102. Both paroxysmal nocturnal hemoglobinuria (PNH) type II cells and PNH type III cells can arise from different point mutations involving the same codon of the PIG-A gene. Rollinson S; Richards S; Norfolk D; Bibi K; Morgan G; Hillmen P Blood; 1997 Apr; 89(8):3069-71. PubMed ID: 9108434 [No Abstract] [Full Text] [Related]
103. The molecular basis of paroxysmal nocturnal hemoglobinuria. Rosse WF; Ware RE Blood; 1995 Nov; 86(9):3277-86. PubMed ID: 7579428 [No Abstract] [Full Text] [Related]
104. Clonal origin of abnormal granulocytes in paroxysmal nocturnal hemoglobinuria. Bessler M; Hillmen P; Luzzatto L Blood; 1992 Aug; 80(3):844-5. PubMed ID: 1638035 [No Abstract] [Full Text] [Related]
105. Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells. Visconte V; Raghavachari N; Liu D; Keyvanfar K; Desierto MJ; Chen J; Young NS Haematologica; 2010 Feb; 95(2):214-23. PubMed ID: 19679885 [TBL] [Abstract][Full Text] [Related]
106. Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria. O'Keefe CL; Sugimori C; Afable M; Clemente M; Shain K; Araten DJ; List A; Epling-Burnette PK; Maciejewski JP Leukemia; 2011 Feb; 25(2):379-82. PubMed ID: 21116280 [No Abstract] [Full Text] [Related]
107. On the dynamics of neutral mutations in a mathematical model for a homogeneous stem cell population. Traulsen A; Lenaerts T; Pacheco JM; Dingli D J R Soc Interface; 2013 Feb; 10(79):20120810. PubMed ID: 23221988 [TBL] [Abstract][Full Text] [Related]
108. Pig-a gene mutations in bone marrow granulocytes of procarbazine-treated F344 rats. Dad A; Revollo JR; Pearce MG; McKinzie PB; Heflich RH; Dobrovolsky VN Environ Mol Mutagen; 2021 Apr; 62(4):265-272. PubMed ID: 33666279 [TBL] [Abstract][Full Text] [Related]
109. The frequency of granulocytes with spontaneous somatic mutations: a wide distribution in a normal human population. Rondelli T; Berardi M; Peruzzi B; Boni L; Caporale R; Dolara P; Notaro R; Luzzatto L PLoS One; 2013; 8(1):e54046. PubMed ID: 23342069 [TBL] [Abstract][Full Text] [Related]
110. Analysis of Lobry C; Bains A; Zamechek LB; Ibrahim S; Aifantis I; Araten DJ Exp Hematol Oncol; 2019; 8():17. PubMed ID: 31453016 [TBL] [Abstract][Full Text] [Related]
113. The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab. Kelly R; Richards S; Hillmen P; Hill A Ther Clin Risk Manag; 2009; 5():911-21. PubMed ID: 20011245 [TBL] [Abstract][Full Text] [Related]
114. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria. Kawaguchi T; Nakakuma H Int J Hematol; 2007 Jul; 86(1):27-32. PubMed ID: 17675263 [TBL] [Abstract][Full Text] [Related]
115. The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). Araten DJ; Luzzatto L Blood; 2006 Jul; 108(2):734-6. PubMed ID: 16543465 [TBL] [Abstract][Full Text] [Related]
116. Molecular genetics of paroxysmal nocturnal hemoglobinuria. Inoue N; Murakami Y; Kinoshita T Int J Hematol; 2003 Feb; 77(2):107-12. PubMed ID: 12627844 [TBL] [Abstract][Full Text] [Related]
117. Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria. Yoon JH; Cho HI; Park SS; Chang YH; Kim BK J Clin Pathol; 2002 Jun; 55(6):410-3. PubMed ID: 12037021 [TBL] [Abstract][Full Text] [Related]